Global Brachytherapy Market

Brachytherapy Comprehensive Study by Type (High Dose Rate (HDR) Brachytherapy , Low Dose (LDR) Brachytherapy), Application (Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Cancers), End User (Hospitals, Radiation Therapy Centers, Ambulatory Surgery Centers, Others) Players and Region - Global Market Outlook to 2029

Brachytherapy Market by XX Submarkets | Forecast Years 2024-2029 | CAGR: 4.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Brachytherapy Market Scope
Rising Prevalence of Prostate Cancer will help to boost the global brachytherapy market. Brachytherapy is also known as internal radiotherapy or seed therapy. Brachytherapy is a kind of radiotherapy that is used in the treatment of different types of cancer such as cervical cancer, breast cancer, skin cancer and other types of cancers. It works by precisely targeting the cancerous tumor from inside the body. The method of aiming cancerous cells by brachytherapy decreases the hazard of any damage to organs and healthy tissues nearby the tumor, thus reducing the potential side effects as well. Furthermore, it is frequently used in combination with chemotherapy drugs to reduce the risk of repetitive cancer.

AttributesDetails
Study Period2019-2029
Base Year2023
High Growth MarketAsia Pacific
Largest MarketNorth America
UnitValue (USD Million)
Key Companies ProfiledEckert & Ziegler BEBIG (Germany), IsoRay Medical, Inc. (United States), Theragenics Corporation (United States), Elekta (Sweden), C.R. Bard, Inc. (Becton Dickinson) (United States), CIVCO Medical Solutions (United States), Sun Nuclear Corporation (United States), iCAD, Inc. (United States), Varian Medical Systems, Inc. (United States) and Argon Medical Devices (United States)
CAGR4.8%


"According to AMA, the Global Brachytherapy market is expected to see growth rate of 4.8% and may see market size of USD452.3 Million by 2029."

The key manufacturers are targeting the innovations of the services with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions in order to maintain their presence in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Brachytherapy market throughout the predicted period.

Eckert & Ziegler BEBIG (Germany), IsoRay Medical, Inc. (United States), Theragenics Corporation (United States), Elekta (Sweden), C.R. Bard, Inc. (Becton Dickinson) (United States), CIVCO Medical Solutions (United States), Sun Nuclear Corporation (United States), iCAD, Inc. (United States), Varian Medical Systems, Inc. (United States) and Argon Medical Devices (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are IsoAid (United States), UAB Health System (United States) and NOMOS (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Brachytherapy market by Type , by Application (Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Cancers) and Region with country level break-up.

On the basis of geography, the market of Brachytherapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Market Leaders and their expansionary development strategies
In October 2023, Elekta AB, a leading provider of radiation therapy solutions, announced the acquisition of Nucleus Medical, Inc., a pioneer in brachytherapy applicators and seed technology. This merger strengthens Elekta's brachytherapy portfolio and provides them with access to Nucleus's innovative seed technology and expertise in gynecological and prostate cancer treatment.
In October 2023, Eckert & Ziegler AG, a German medical technology company, launched the Selectron™ HDR100 afterloader, a next-generation system for high-dose-rate brachytherapy. This new afterloader features advanced software and automation capabilities, aiming to optimize treatment delivery and safety.
According to the International Agency for Research on Cancer, in 2015, more than 15 million people suffered from cancer while 8.8 million deaths were caused by the disease worldwide. This number is expected to rise to 24 million by 2035. It is also estimated that 23.6 million new cancer cases will be diagnosed by 2030. In addition to this, according to American Brachytherapy Society, safety, and efficacy of brachytherapy treatment over other cancer treatments, such as chemotherapy and surgery, is expected to boost the market. In addition, favorable reimbursement guidelines are expected to contribute in rising adoption of brachytherapy.

Influencing Trend:
Increasing Medical Expenditure in Enhancing Cancer Treatments and Robust Research and Developments in Developing Brachytherapy Treatments

Market Growth Drivers:
Growing Prevalence of Prostate Cancer and High Adoption Due To Re-Occurrence of Cancer in the Patient Treated with Brachytherapy is Rare

Challenges:
Lack of Skilled Radiologists and Expertise to Provide Brachytherapy Treatments

Restraints:
Numerous Side Effects Incorporated with the Brachytherapy Treatments

Opportunities:
Technological Developments in the Field Of Oncology Treatment and Increasing Knowledge about the Different Advantages of Brachytherapy among Healthcare Practitioners

Key Target Audience
Contract Research Organizations (CROs), Research and Development (R&D) Companies, Academic Medical Institutes and Universities, Government Regulatory Bodies, Government Research Institutes and Others

Report Objectives / Segmentation Covered

By Type
  • High Dose Rate (HDR) Brachytherapy 
  • Low Dose (LDR) Brachytherapy
By Application
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Other Cancers
By End User
  • Hospitals
  • Radiation Therapy Centers
  • Ambulatory Surgery Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Prostate Cancer
      • 3.2.2. High Adoption Due To Re-Occurrence of Cancer in the Patient Treated with Brachytherapy is Rare
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Radiologists and Expertise to Provide Brachytherapy Treatments
    • 3.4. Market Trends
      • 3.4.1. Increasing Medical Expenditure in Enhancing Cancer Treatments
      • 3.4.2. Robust Research and Developments in Developing Brachytherapy Treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brachytherapy, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Brachytherapy (Value)
      • 5.2.1. Global Brachytherapy by: Type (Value)
        • 5.2.1.1. High Dose Rate (HDR) Brachytherapy 
        • 5.2.1.2. Low Dose (LDR) Brachytherapy
      • 5.2.2. Global Brachytherapy by: Application (Value)
        • 5.2.2.1. Prostate Cancer
        • 5.2.2.2. Gynecological Cancer
        • 5.2.2.3. Breast Cancer
        • 5.2.2.4. Other Cancers
      • 5.2.3. Global Brachytherapy by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Radiation Therapy Centers
        • 5.2.3.3. Ambulatory Surgery Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Brachytherapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Brachytherapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eckert & Ziegler BEBIG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IsoRay Medical, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Theragenics Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elekta (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C.R. Bard, Inc. (Becton Dickinson) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CIVCO Medical Solutions (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sun Nuclear Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ICAD, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Varian Medical Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Argon Medical Devices (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Brachytherapy Sale, by Type, Application, End User and Region (value) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Brachytherapy (Value)
      • 7.2.1. Global Brachytherapy by: Type (Value)
        • 7.2.1.1. High Dose Rate (HDR) Brachytherapy 
        • 7.2.1.2. Low Dose (LDR) Brachytherapy
      • 7.2.2. Global Brachytherapy by: Application (Value)
        • 7.2.2.1. Prostate Cancer
        • 7.2.2.2. Gynecological Cancer
        • 7.2.2.3. Breast Cancer
        • 7.2.2.4. Other Cancers
      • 7.2.3. Global Brachytherapy by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Radiation Therapy Centers
        • 7.2.3.3. Ambulatory Surgery Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Brachytherapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brachytherapy: by Type(USD Million)
  • Table 2. Brachytherapy High Dose Rate (HDR) Brachytherapy  , by Region USD Million (2018-2023)
  • Table 3. Brachytherapy Low Dose (LDR) Brachytherapy , by Region USD Million (2018-2023)
  • Table 4. Brachytherapy: by Application(USD Million)
  • Table 5. Brachytherapy Prostate Cancer , by Region USD Million (2018-2023)
  • Table 6. Brachytherapy Gynecological Cancer , by Region USD Million (2018-2023)
  • Table 7. Brachytherapy Breast Cancer , by Region USD Million (2018-2023)
  • Table 8. Brachytherapy Other Cancers , by Region USD Million (2018-2023)
  • Table 9. Brachytherapy: by End User(USD Million)
  • Table 10. Brachytherapy Hospitals , by Region USD Million (2018-2023)
  • Table 11. Brachytherapy Radiation Therapy Centers , by Region USD Million (2018-2023)
  • Table 12. Brachytherapy Ambulatory Surgery Centers , by Region USD Million (2018-2023)
  • Table 13. Brachytherapy Others , by Region USD Million (2018-2023)
  • Table 14. South America Brachytherapy, by Country USD Million (2018-2023)
  • Table 15. South America Brachytherapy, by Type USD Million (2018-2023)
  • Table 16. South America Brachytherapy, by Application USD Million (2018-2023)
  • Table 17. South America Brachytherapy, by End User USD Million (2018-2023)
  • Table 18. Brazil Brachytherapy, by Type USD Million (2018-2023)
  • Table 19. Brazil Brachytherapy, by Application USD Million (2018-2023)
  • Table 20. Brazil Brachytherapy, by End User USD Million (2018-2023)
  • Table 21. Argentina Brachytherapy, by Type USD Million (2018-2023)
  • Table 22. Argentina Brachytherapy, by Application USD Million (2018-2023)
  • Table 23. Argentina Brachytherapy, by End User USD Million (2018-2023)
  • Table 24. Rest of South America Brachytherapy, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Brachytherapy, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Brachytherapy, by End User USD Million (2018-2023)
  • Table 27. Asia Pacific Brachytherapy, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Brachytherapy, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Brachytherapy, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Brachytherapy, by End User USD Million (2018-2023)
  • Table 31. China Brachytherapy, by Type USD Million (2018-2023)
  • Table 32. China Brachytherapy, by Application USD Million (2018-2023)
  • Table 33. China Brachytherapy, by End User USD Million (2018-2023)
  • Table 34. Japan Brachytherapy, by Type USD Million (2018-2023)
  • Table 35. Japan Brachytherapy, by Application USD Million (2018-2023)
  • Table 36. Japan Brachytherapy, by End User USD Million (2018-2023)
  • Table 37. India Brachytherapy, by Type USD Million (2018-2023)
  • Table 38. India Brachytherapy, by Application USD Million (2018-2023)
  • Table 39. India Brachytherapy, by End User USD Million (2018-2023)
  • Table 40. South Korea Brachytherapy, by Type USD Million (2018-2023)
  • Table 41. South Korea Brachytherapy, by Application USD Million (2018-2023)
  • Table 42. South Korea Brachytherapy, by End User USD Million (2018-2023)
  • Table 43. Taiwan Brachytherapy, by Type USD Million (2018-2023)
  • Table 44. Taiwan Brachytherapy, by Application USD Million (2018-2023)
  • Table 45. Taiwan Brachytherapy, by End User USD Million (2018-2023)
  • Table 46. Australia Brachytherapy, by Type USD Million (2018-2023)
  • Table 47. Australia Brachytherapy, by Application USD Million (2018-2023)
  • Table 48. Australia Brachytherapy, by End User USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Brachytherapy, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Brachytherapy, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Brachytherapy, by End User USD Million (2018-2023)
  • Table 52. Europe Brachytherapy, by Country USD Million (2018-2023)
  • Table 53. Europe Brachytherapy, by Type USD Million (2018-2023)
  • Table 54. Europe Brachytherapy, by Application USD Million (2018-2023)
  • Table 55. Europe Brachytherapy, by End User USD Million (2018-2023)
  • Table 56. Germany Brachytherapy, by Type USD Million (2018-2023)
  • Table 57. Germany Brachytherapy, by Application USD Million (2018-2023)
  • Table 58. Germany Brachytherapy, by End User USD Million (2018-2023)
  • Table 59. France Brachytherapy, by Type USD Million (2018-2023)
  • Table 60. France Brachytherapy, by Application USD Million (2018-2023)
  • Table 61. France Brachytherapy, by End User USD Million (2018-2023)
  • Table 62. Italy Brachytherapy, by Type USD Million (2018-2023)
  • Table 63. Italy Brachytherapy, by Application USD Million (2018-2023)
  • Table 64. Italy Brachytherapy, by End User USD Million (2018-2023)
  • Table 65. United Kingdom Brachytherapy, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Brachytherapy, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Brachytherapy, by End User USD Million (2018-2023)
  • Table 68. Netherlands Brachytherapy, by Type USD Million (2018-2023)
  • Table 69. Netherlands Brachytherapy, by Application USD Million (2018-2023)
  • Table 70. Netherlands Brachytherapy, by End User USD Million (2018-2023)
  • Table 71. Rest of Europe Brachytherapy, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Brachytherapy, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Brachytherapy, by End User USD Million (2018-2023)
  • Table 74. MEA Brachytherapy, by Country USD Million (2018-2023)
  • Table 75. MEA Brachytherapy, by Type USD Million (2018-2023)
  • Table 76. MEA Brachytherapy, by Application USD Million (2018-2023)
  • Table 77. MEA Brachytherapy, by End User USD Million (2018-2023)
  • Table 78. Middle East Brachytherapy, by Type USD Million (2018-2023)
  • Table 79. Middle East Brachytherapy, by Application USD Million (2018-2023)
  • Table 80. Middle East Brachytherapy, by End User USD Million (2018-2023)
  • Table 81. Africa Brachytherapy, by Type USD Million (2018-2023)
  • Table 82. Africa Brachytherapy, by Application USD Million (2018-2023)
  • Table 83. Africa Brachytherapy, by End User USD Million (2018-2023)
  • Table 84. North America Brachytherapy, by Country USD Million (2018-2023)
  • Table 85. North America Brachytherapy, by Type USD Million (2018-2023)
  • Table 86. North America Brachytherapy, by Application USD Million (2018-2023)
  • Table 87. North America Brachytherapy, by End User USD Million (2018-2023)
  • Table 88. United States Brachytherapy, by Type USD Million (2018-2023)
  • Table 89. United States Brachytherapy, by Application USD Million (2018-2023)
  • Table 90. United States Brachytherapy, by End User USD Million (2018-2023)
  • Table 91. Canada Brachytherapy, by Type USD Million (2018-2023)
  • Table 92. Canada Brachytherapy, by Application USD Million (2018-2023)
  • Table 93. Canada Brachytherapy, by End User USD Million (2018-2023)
  • Table 94. Mexico Brachytherapy, by Type USD Million (2018-2023)
  • Table 95. Mexico Brachytherapy, by Application USD Million (2018-2023)
  • Table 96. Mexico Brachytherapy, by End User USD Million (2018-2023)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Brachytherapy: by Type(USD Million)
  • Table 108. Brachytherapy High Dose Rate (HDR) Brachytherapy  , by Region USD Million (2024-2029)
  • Table 109. Brachytherapy Low Dose (LDR) Brachytherapy , by Region USD Million (2024-2029)
  • Table 110. Brachytherapy: by Application(USD Million)
  • Table 111. Brachytherapy Prostate Cancer , by Region USD Million (2024-2029)
  • Table 112. Brachytherapy Gynecological Cancer , by Region USD Million (2024-2029)
  • Table 113. Brachytherapy Breast Cancer , by Region USD Million (2024-2029)
  • Table 114. Brachytherapy Other Cancers , by Region USD Million (2024-2029)
  • Table 115. Brachytherapy: by End User(USD Million)
  • Table 116. Brachytherapy Hospitals , by Region USD Million (2024-2029)
  • Table 117. Brachytherapy Radiation Therapy Centers , by Region USD Million (2024-2029)
  • Table 118. Brachytherapy Ambulatory Surgery Centers , by Region USD Million (2024-2029)
  • Table 119. Brachytherapy Others , by Region USD Million (2024-2029)
  • Table 120. South America Brachytherapy, by Country USD Million (2024-2029)
  • Table 121. South America Brachytherapy, by Type USD Million (2024-2029)
  • Table 122. South America Brachytherapy, by Application USD Million (2024-2029)
  • Table 123. South America Brachytherapy, by End User USD Million (2024-2029)
  • Table 124. Brazil Brachytherapy, by Type USD Million (2024-2029)
  • Table 125. Brazil Brachytherapy, by Application USD Million (2024-2029)
  • Table 126. Brazil Brachytherapy, by End User USD Million (2024-2029)
  • Table 127. Argentina Brachytherapy, by Type USD Million (2024-2029)
  • Table 128. Argentina Brachytherapy, by Application USD Million (2024-2029)
  • Table 129. Argentina Brachytherapy, by End User USD Million (2024-2029)
  • Table 130. Rest of South America Brachytherapy, by Type USD Million (2024-2029)
  • Table 131. Rest of South America Brachytherapy, by Application USD Million (2024-2029)
  • Table 132. Rest of South America Brachytherapy, by End User USD Million (2024-2029)
  • Table 133. Asia Pacific Brachytherapy, by Country USD Million (2024-2029)
  • Table 134. Asia Pacific Brachytherapy, by Type USD Million (2024-2029)
  • Table 135. Asia Pacific Brachytherapy, by Application USD Million (2024-2029)
  • Table 136. Asia Pacific Brachytherapy, by End User USD Million (2024-2029)
  • Table 137. China Brachytherapy, by Type USD Million (2024-2029)
  • Table 138. China Brachytherapy, by Application USD Million (2024-2029)
  • Table 139. China Brachytherapy, by End User USD Million (2024-2029)
  • Table 140. Japan Brachytherapy, by Type USD Million (2024-2029)
  • Table 141. Japan Brachytherapy, by Application USD Million (2024-2029)
  • Table 142. Japan Brachytherapy, by End User USD Million (2024-2029)
  • Table 143. India Brachytherapy, by Type USD Million (2024-2029)
  • Table 144. India Brachytherapy, by Application USD Million (2024-2029)
  • Table 145. India Brachytherapy, by End User USD Million (2024-2029)
  • Table 146. South Korea Brachytherapy, by Type USD Million (2024-2029)
  • Table 147. South Korea Brachytherapy, by Application USD Million (2024-2029)
  • Table 148. South Korea Brachytherapy, by End User USD Million (2024-2029)
  • Table 149. Taiwan Brachytherapy, by Type USD Million (2024-2029)
  • Table 150. Taiwan Brachytherapy, by Application USD Million (2024-2029)
  • Table 151. Taiwan Brachytherapy, by End User USD Million (2024-2029)
  • Table 152. Australia Brachytherapy, by Type USD Million (2024-2029)
  • Table 153. Australia Brachytherapy, by Application USD Million (2024-2029)
  • Table 154. Australia Brachytherapy, by End User USD Million (2024-2029)
  • Table 155. Rest of Asia-Pacific Brachytherapy, by Type USD Million (2024-2029)
  • Table 156. Rest of Asia-Pacific Brachytherapy, by Application USD Million (2024-2029)
  • Table 157. Rest of Asia-Pacific Brachytherapy, by End User USD Million (2024-2029)
  • Table 158. Europe Brachytherapy, by Country USD Million (2024-2029)
  • Table 159. Europe Brachytherapy, by Type USD Million (2024-2029)
  • Table 160. Europe Brachytherapy, by Application USD Million (2024-2029)
  • Table 161. Europe Brachytherapy, by End User USD Million (2024-2029)
  • Table 162. Germany Brachytherapy, by Type USD Million (2024-2029)
  • Table 163. Germany Brachytherapy, by Application USD Million (2024-2029)
  • Table 164. Germany Brachytherapy, by End User USD Million (2024-2029)
  • Table 165. France Brachytherapy, by Type USD Million (2024-2029)
  • Table 166. France Brachytherapy, by Application USD Million (2024-2029)
  • Table 167. France Brachytherapy, by End User USD Million (2024-2029)
  • Table 168. Italy Brachytherapy, by Type USD Million (2024-2029)
  • Table 169. Italy Brachytherapy, by Application USD Million (2024-2029)
  • Table 170. Italy Brachytherapy, by End User USD Million (2024-2029)
  • Table 171. United Kingdom Brachytherapy, by Type USD Million (2024-2029)
  • Table 172. United Kingdom Brachytherapy, by Application USD Million (2024-2029)
  • Table 173. United Kingdom Brachytherapy, by End User USD Million (2024-2029)
  • Table 174. Netherlands Brachytherapy, by Type USD Million (2024-2029)
  • Table 175. Netherlands Brachytherapy, by Application USD Million (2024-2029)
  • Table 176. Netherlands Brachytherapy, by End User USD Million (2024-2029)
  • Table 177. Rest of Europe Brachytherapy, by Type USD Million (2024-2029)
  • Table 178. Rest of Europe Brachytherapy, by Application USD Million (2024-2029)
  • Table 179. Rest of Europe Brachytherapy, by End User USD Million (2024-2029)
  • Table 180. MEA Brachytherapy, by Country USD Million (2024-2029)
  • Table 181. MEA Brachytherapy, by Type USD Million (2024-2029)
  • Table 182. MEA Brachytherapy, by Application USD Million (2024-2029)
  • Table 183. MEA Brachytherapy, by End User USD Million (2024-2029)
  • Table 184. Middle East Brachytherapy, by Type USD Million (2024-2029)
  • Table 185. Middle East Brachytherapy, by Application USD Million (2024-2029)
  • Table 186. Middle East Brachytherapy, by End User USD Million (2024-2029)
  • Table 187. Africa Brachytherapy, by Type USD Million (2024-2029)
  • Table 188. Africa Brachytherapy, by Application USD Million (2024-2029)
  • Table 189. Africa Brachytherapy, by End User USD Million (2024-2029)
  • Table 190. North America Brachytherapy, by Country USD Million (2024-2029)
  • Table 191. North America Brachytherapy, by Type USD Million (2024-2029)
  • Table 192. North America Brachytherapy, by Application USD Million (2024-2029)
  • Table 193. North America Brachytherapy, by End User USD Million (2024-2029)
  • Table 194. United States Brachytherapy, by Type USD Million (2024-2029)
  • Table 195. United States Brachytherapy, by Application USD Million (2024-2029)
  • Table 196. United States Brachytherapy, by End User USD Million (2024-2029)
  • Table 197. Canada Brachytherapy, by Type USD Million (2024-2029)
  • Table 198. Canada Brachytherapy, by Application USD Million (2024-2029)
  • Table 199. Canada Brachytherapy, by End User USD Million (2024-2029)
  • Table 200. Mexico Brachytherapy, by Type USD Million (2024-2029)
  • Table 201. Mexico Brachytherapy, by Application USD Million (2024-2029)
  • Table 202. Mexico Brachytherapy, by End User USD Million (2024-2029)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brachytherapy: by Type USD Million (2018-2023)
  • Figure 5. Global Brachytherapy: by Application USD Million (2018-2023)
  • Figure 6. Global Brachytherapy: by End User USD Million (2018-2023)
  • Figure 7. South America Brachytherapy Share (%), by Country
  • Figure 8. Asia Pacific Brachytherapy Share (%), by Country
  • Figure 9. Europe Brachytherapy Share (%), by Country
  • Figure 10. MEA Brachytherapy Share (%), by Country
  • Figure 11. North America Brachytherapy Share (%), by Country
  • Figure 12. Global Brachytherapy share by Players 2023 (%)
  • Figure 13. Global Brachytherapy share by Players (Top 3) 2023(%)
  • Figure 14. Global Brachytherapy share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Eckert & Ziegler BEBIG (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Eckert & Ziegler BEBIG (Germany) Revenue: by Geography 2023
  • Figure 18. IsoRay Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. IsoRay Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Theragenics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Theragenics Corporation (United States) Revenue: by Geography 2023
  • Figure 22. Elekta (Sweden) Revenue, Net Income and Gross profit
  • Figure 23. Elekta (Sweden) Revenue: by Geography 2023
  • Figure 24. C.R. Bard, Inc. (Becton Dickinson) (United States) Revenue, Net Income and Gross profit
  • Figure 25. C.R. Bard, Inc. (Becton Dickinson) (United States) Revenue: by Geography 2023
  • Figure 26. CIVCO Medical Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 27. CIVCO Medical Solutions (United States) Revenue: by Geography 2023
  • Figure 28. Sun Nuclear Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Sun Nuclear Corporation (United States) Revenue: by Geography 2023
  • Figure 30. ICAD, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. ICAD, Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Argon Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 35. Argon Medical Devices (United States) Revenue: by Geography 2023
  • Figure 36. Global Brachytherapy: by Type USD Million (2024-2029)
  • Figure 37. Global Brachytherapy: by Application USD Million (2024-2029)
  • Figure 38. Global Brachytherapy: by End User USD Million (2024-2029)
  • Figure 39. South America Brachytherapy Share (%), by Country
  • Figure 40. Asia Pacific Brachytherapy Share (%), by Country
  • Figure 41. Europe Brachytherapy Share (%), by Country
  • Figure 42. MEA Brachytherapy Share (%), by Country
  • Figure 43. North America Brachytherapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eckert & Ziegler BEBIG (Germany)
  • IsoRay Medical, Inc. (United States)
  • Theragenics Corporation (United States)
  • Elekta (Sweden)
  • C.R. Bard, Inc. (Becton Dickinson) (United States)
  • CIVCO Medical Solutions (United States)
  • Sun Nuclear Corporation (United States)
  • iCAD, Inc. (United States)
  • Varian Medical Systems, Inc. (United States)
  • Argon Medical Devices (United States)
Additional players considered in the study are as follows:
IsoAid (United States) , UAB Health System (United States) , NOMOS (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 167 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Brachytherapy Market Quantitative research analysis
Global Brachytherapy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Brachytherapy Market are by type [High Dose Rate (HDR) Brachytherapy  and Low Dose (LDR) Brachytherapy], by end use application [Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Cancers].
The Brachytherapy Market is gaining popularity and expected to see strong valuation by 2029.
  • Growing Prevalence of Prostate Cancer
  • High Adoption Due To Re-Occurrence of Cancer in the Patient Treated with Brachytherapy is Rare

Know More About Global Brachytherapy Market Report?

Have a Query? Click Here

Other Related Reports

Q Fever Comprehensive Study by Type (Acute Q Fever, Chronic Q Fever), Treatment (Medicines (Doxycycline), Vaccination), End-users (Hospitals & Clinics, Diagnostic Centers, Surgical Centers), Diagnosi...
$ 3450
Mumps Virus Testing Comprehensive Study by Type (Cell Culture/Immunofluorescence, Semi-Quantitative Enzyme-Linked Immunosorbent Assay, Semi-Quantitative Chemiluminescent Immunoassay, Qualitative Real...
$ 3450
Colon Cancer Comprehensive Study by Type (Surgery, Chemotherapy, Radiation), Application (Hospitals, Ambulatory Surgical Centers, Others), Testing Techniques (Macroscopy, Microscopy, Immunochemistry,...
$ 3750
Dysphagia Management Comprehensive Study by Type (High (Oropharangeal) Dysphagia, Low (Esophageal) Dysphagia), Application (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Specialty Clinics) Pla...
$ 3500
Combination Antibody Therapy Comprehensive Study by Type (Chemotherapy/Antibody, Antibody/Antibody, Conjugated Antibodies, Bispecific Antibodies), Application (Lung Cancer, Blood Cancer (Lymphoma, Le...
$ 3650
Carcinoid Syndrome Diarrhea Treatment Comprehensive Study by End User (Hospitals and Clinics, Cancer Research Institutes, Others), Treatment (Chemotherapy, Oral Therapy, Somatostatin Analog (SSA) Th...
$ 3500